The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 04, 2020

Filed:

Oct. 19, 2016
Applicant:

Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP;

Inventors:

Takahiro Sugimoto, Kanagawa, JP;

Shinkichi Suzuki, Kanagawa, JP;

Hiroki Sakamoto, Kanagawa, JP;

Masami Yamada, Kanagawa, JP;

Minoru Nakamura, Kanagawa, JP;

Makoto Kamata, Kanagawa, JP;

Kenichiro Shimokawa, Kanagawa, JP;

Masaki Ogino, Kanagawa, JP;

Eiji Kimura, Kanagawa, JP;

Masataka Murakami, Kanagawa, JP;

Takuto Kojima, Kanagawa, JP;

Jinichi Yonemori, Kanagawa, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/53 (2006.01); A61K 31/517 (2006.01); C07D 403/06 (2006.01); C07D 403/10 (2006.01); C07D 405/14 (2006.01); C07D 401/14 (2006.01); C07D 239/88 (2006.01); C07D 401/06 (2006.01); A61P 25/28 (2006.01); A61P 25/04 (2006.01); A61P 25/18 (2006.01); A61P 25/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/53 (2013.01); A61K 31/517 (2013.01); A61P 25/04 (2018.01); A61P 25/16 (2018.01); A61P 25/18 (2018.01); A61P 25/28 (2018.01); C07D 239/88 (2013.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 403/10 (2013.01); C07D 405/14 (2013.01);
Abstract

The present invention provides a compound which has a cholinergic muscarinic M1 receptor positive allosteric modulator activity and may be useful as a medicament such as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, Lewy body dementia and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. In the formula (I), each symbol is as described in the attached specification.


Find Patent Forward Citations

Loading…